A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

NCT ID: NCT06311721

Last Updated: 2026-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

315 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-09

Study Completion Date

2028-05-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ABP 234

Part 1: Participants will receive ABP 234 followed by pemetrexed administered with platinum-based chemotherapy (cisplatin or carboplatin). Part 2: Participants will receive ABP 234 followed by pemetrexed.

Group Type EXPERIMENTAL

ABP 234

Intervention Type DRUG

Intravenous administration

Pembrolizumab (US)

Part 1: Participants will receive FDA-licensed pembrolizumab followed by pemetrexed administered with platinum-based chemotherapy (cisplatin or carboplatin). Part 2: Participants will receive FDA-licensed pembrolizumab followed by pemetrexed.

Group Type EXPERIMENTAL

Pembrolizumab (US)

Intervention Type DRUG

Intravenous administration

Pembrolizumab (EU)

Part 1: Participants will receive EU-approved pembrolizumab followed by pemetrexed administered with platinum-based chemotherapy (cisplatin or carboplatin). Part 2: Participants will receive EU-approved pembrolizumab followed by pemetrexed.

Group Type EXPERIMENTAL

Pembrolizumab (EU)

Intervention Type DRUG

Intravenous administration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ABP 234

Intravenous administration

Intervention Type DRUG

Pembrolizumab (US)

Intravenous administration

Intervention Type DRUG

Pembrolizumab (EU)

Intravenous administration

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Keytruda® Keytruda®

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. At least 18 years of age.
2. Histologically or cytologically confirmed stage IV non-squamous Non-Small Cell Lung Cancer (NSCLC).
3. Participant has no prior systemic treatment for advanced disease.
4. Measurable disease according to RECIST v1.1.
5. Tumor tissue from the resected site of disease must be available for biomarker analyses in order to be randomized.
6. Eastern Cooperative Oncology Group performance status score 0 or 1.
7. Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and c-ros oncogene 1, receptor tyrosine kinase of the insulin receptor family (ROS-1) negative
8. Have a life expectancy of at least 3 months.

Exclusion Criteria

1. Small cell lung cancer (SCLC) or mixed SCLC/NSCLC histology or squamous cell carcinoma.
2. Participant has active central nervous system metastases not previously treated.
3. Participant has active or known immune-mediated disorders.
4. Participant has received prior systemic cytotoxic chemotherapy, immunotherapy (including PD-1/PD-L1), anti-neoplastic biological therapy, or targeted therapy for advanced/metastatic disease.
5. Known hypersensitivity to monoclonal antibodies or to any of the excipients of the study drug, or to any component of cisplatin, carboplatin, or pemetrexed.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Precision NextGen Oncology and Research Center

Beverly Hills, California, United States

Site Status

TOI Clinical Research

Cerritos, California, United States

Site Status

Cancer and Blood Specialty Clinic (CBSC)

Los Alamitos, California, United States

Site Status

Valkyrie Clinical Trials

Los Angeles, California, United States

Site Status

PIH Health Hospital

Whittier, California, United States

Site Status

Millennium Oncology - Hollywood

Hollywood, Florida, United States

Site Status

BRCR Medical Center Inc.

Tamarac, Florida, United States

Site Status

Accellacare Duly

Plainfield, Illinois, United States

Site Status

Accellacare of McFarland

Ames, Iowa, United States

Site Status

Detroit Clinical Research Center, PC

Farmington Hills, Michigan, United States

Site Status

North Shore Hematology-Oncology Associates P.C. d/b/a New York Cancer & Blood Specialists

Shirley, New York, United States

Site Status

Gabrail Cancer Center Research

Canton, Ohio, United States

Site Status

Millennium Research and Clinical Development, LLC

Houston, Texas, United States

Site Status

Texas Oncology, P.A

San Antonio, Texas, United States

Site Status

Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care

Wytheville, Virginia, United States

Site Status

Instituto de Investigaciones Clinicas Mar del Plata

Mar del Plata, Buenos Aires, Argentina

Site Status

Centro de Investigacion Pergamino SA

Pergamino, Buenos Aires, Argentina

Site Status

Fundacion ARS Medica

San Salvador de Jujuy, Jujuy Province, Argentina

Site Status

Sanatorio Britanico De Rosario

Rosario, Santa Fe Province, Argentina

Site Status

Hospital Provincial del Centenario

Rosario, Santa Fe Province, Argentina

Site Status

IONC - Instituto Oncologico de Cordoba

Córdoba, , Argentina

Site Status

Klinikum Klagenfurt am Woerthersee

Klagenfurt, , Austria

Site Status

Ordensklinikum Linz GmbH Elisabethinen

Linz, , Austria

Site Status

CRIO - Centro Regional Integrado de Oncologia

Fortaleza, Ceará, Brazil

Site Status

OC Oncoclinicas Oncovida

Brasília, Destrito Federal, Brazil

Site Status

Centro de Pesquisas Clinicas em Oncologia (CPCO)/HECI

Cachoeiro de Itapemirim, Espírito Santo, Brazil

Site Status

Associacao Feminina de Educacao e Combate ao Cancer(AFECC) - Hospital Santa Rita

Vitória, Espírito Santo, Brazil

Site Status

Hospital Santa Izabel, Santa Casa de Misericordia da Bahia

Salvador, Estado de Bahia, Brazil

Site Status

Cetus Oncologia S.A. Unidade Belo Horizonte

Belo Horizonte, Minas Gerais, Brazil

Site Status

Nucleo de Ensino Pesquisa e Inovacao Mario Penna

Belo Horizonte, Minas Gerais, Brazil

Site Status

Fundacao Sao Francisco Xavier - Hospital Marcio Cunha (HMC) - Unidade I

Ipatinga, Minas Gerais, Brazil

Site Status

Liga Paranaense de Combate ao Cancer - Hospital Erasto Gaertner

Curitiba, Paraná, Brazil

Site Status

Instituto de Cancer de Londrina - Hospital do Cancer de Londrina - HCL

Londrina, Paraná, Brazil

Site Status

Liga Contra o Cancer

Natal, Rio Grande do Norte, Brazil

Site Status

Hospital Tacchini

Bento Gonçalves, Rio Grande do Sul, Brazil

Site Status

Oncosite Centro De Pesquisa Clinica Em Oncologia

Ijuí, Rio Grande do Sul, Brazil

Site Status

Hospital Bruno Born

Lajeado, Rio Grande do Sul, Brazil

Site Status

Hospital da Cidade de Passo Fundo - HCPF

Passo Fundo, Rio Grande do Sul, Brazil

Site Status

Unidade de Pesquisa Clinica em Oncologia Ltda (UPCO) (Clinica Lacks)

Pelotas, Rio Grande do Sul, Brazil

Site Status

Centro de Pesquisa em Oncologia - Hospital Sao Lucas da PUC Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Associacao dos Functionarios Publicos do Estado do Rio Grande do Sul - Hospital Ernesto Dornelles (H

Porto Alegre Rio Grande Do Sul, Rio Grande do Sul, Brazil

Site Status

Centro de Oncologia de Santa Catarina Ltda / Supera Oncologia

Chapecó, Santa Catarina, Brazil

Site Status

CEPEN Centro de Pesquisa e Ensino em Saude de Santa Catarina

Florianópolis, Santa Catarina, Brazil

Site Status

Instituto Joinvillense de Hematologia e Oncologia SS Ltda - Clinica de Hematologia e Oncologia

Joinville, Santa Catarina, Brazil

Site Status

Fundacao Pio XII - Hospital de Cancer de Barretos

Barretos, São Paulo, Brazil

Site Status

Centro de Pesquisa Sao Lucas

Campinas, São Paulo, Brazil

Site Status

Centro Oncologico Mogi das Cruzes

Mogi das Cruzes, São Paulo, Brazil

Site Status

Instituto Ribeiraopretano de Combate ao Cancer (IRPCc) - IRPCC

Ribeirão Preto, São Paulo, Brazil

Site Status

Faculdade de Medicina do ABC - Centro de Estudos e Pesqulsas de Hematologia e Oncologia

Santo André, São Paulo, Brazil

Site Status

Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto - Hospital de Base de Sao Jose do R

São José do Rio Preto, São Paulo, Brazil

Site Status

Hospital Nossa Senhora das Gracas

Canoas, , Brazil

Site Status

CIONC - Centro Integrado de Oncologia de Curitiba

Curitiba, , Brazil

Site Status

Centro Integrado de Pesquisa em Oncologia - Hospital Nossa Senhora da Conceio

Porto Alegre, , Brazil

Site Status

Instituto Nacional de Cancer (INCA)

Rio de Janeiro, , Brazil

Site Status

Instituto Americas - Ensino, Pesquisa e Inovacao

Rio de Janeiro, , Brazil

Site Status

Oncoclinicas Rio de Janeiro S.A (Centro de Tratamento de Tumores Botafogo)

Rio de Janeiro - RJ, , Brazil

Site Status

Instituto D'Or de Pesquisa e Ensino - Hospital Sao Rafael

Salvador, , Brazil

Site Status

Hospital Alemao Oswaldo Cruz (HAOC)

São Paulo, , Brazil

Site Status

Instituto Brasileiro de Controle do Cancer - IBCC Oncologia

São Paulo, , Brazil

Site Status

University Multi-Profile Hospital for Active Treatment (UMHAT) St. Ivan Rilski

Sofia, Sofia-Grad, Bulgaria

Site Status

MHAT Dobrich AD

Dobrich, , Bulgaria

Site Status

University Multiprofile Hospital for Active Treatment Sofiamed

Sofia, , Bulgaria

Site Status

Oncocentro

Viña del Mar, Región de Valparaíso, Chile

Site Status

Centro de Investigaciones Clinicas Vina del Mar Ltda.

Viña del Mar, Región de Valparaíso, Chile

Site Status

CDIEM - Centro de Investigacion y Especialidades Medicas

Providencia, Santiago Metropolitan, Chile

Site Status

Centro de Oncologa de Precisin

Region Metropolitana, Santiago Metropolitan, Chile

Site Status

Clinica Santa Maria

Santiago, Santiago Metropolitan, Chile

Site Status

K2 Oncology

Santiago, , Chile

Site Status

Icegclinic Research and Care

Santiago, , Chile

Site Status

Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre

Bordeaux, , France

Site Status

Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren

Limoges, , France

Site Status

Hopital Europeen Marseille

Marseille, , France

Site Status

Clinique Clementville-Gcs Centre De Cancerologie Du Grand Montpellier

Montpellier, , France

Site Status

Centre Hospitalier Universitaire de Nimes (CHU) - Hopital Universitaire Caremeau

Nîmes, , France

Site Status

Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hospital Font-Pre

Toulon, , France

Site Status

Clinique Teissier

Valenciennes, , France

Site Status

Hopital Robert Schuman

Vantoux, , France

Site Status

High Technology Hospital Medcenter LTD

Batumi, , Georgia

Site Status

Israel-Georgian Medical Research Clinic Healthycore

Tbilisi, , Georgia

Site Status

LLC Todua Clinic

Tbilisi, , Georgia

Site Status

TIM -Tbilisi Institute of Medicine

Tbilisi, , Georgia

Site Status

New Hospitals

Tbilisi, , Georgia

Site Status

Medulla - Clinics And Medical Centers

Tbilisi, , Georgia

Site Status

Evang. Kliniken Essen Mitte GmbH

Essen, , Germany

Site Status

Studienzentrum Aschaffenburg

Hösbach, , Germany

Site Status

Haematologie, Onkologie und Palliativmedizin, Tagesklinik Landshut

Landshut, , Germany

Site Status

FEK - Friedrich-Ebert-Krankenhaus Neumuenster GmbH

Neumünster, , Germany

Site Status

Azienda Ospedaliero - Universitaria di Ferrara

Cona, , Italy

Site Status

Azienda Socio Sanitaria Territoriale di Cremona

Cremona, , Italy

Site Status

Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico Di Milano

Milan, , Italy

Site Status

UOC Oncoematologia AOU Luigi Vanvitelli

Naples, , Italy

Site Status

ASL Napoli 1 Centro-Ospedale del Mare

Napoli, , Italy

Site Status

AUSL Della Romagna - Ospedale S.Maria delle Croci

Ravenna, , Italy

Site Status

S.C. Oncologia Medica-Presidio Ospedaliero Sondrio

Sondrio, , Italy

Site Status

Azienda Ospedaliera Santa Maria Terni

Terni, , Italy

Site Status

Japan Community Healthcare Organization Chukyo Hospital

Nagoya, Aichi-ken, Japan

Site Status

Funabashi Municipal Medical Center

Funabashi-shi, Chiba, Japan

Site Status

Kyushu University Hospital

Fukuoka, Fukuoka, Japan

Site Status

Aso Iizuka Hospital

Iizuka-shi, Fukuoka, Japan

Site Status

Japanese Red Cross Maebashi Hospital

Maebashi, Gunma, Japan

Site Status

Chugoku Central Hospital

Fukuyama, Hiroshima, Japan

Site Status

Hiroshima Prefectural Hospital

Hiroshima, Hiroshima, Japan

Site Status

Asahikawa Medical University Hospital

Asahikawa, Hokkaido, Japan, Japan

Site Status

Hyogo Prefectural Amagasaki General Medical Center

Amagasaki, Hyōgo, Japan

Site Status

Nippon Medical School Musashikosugi Hospital

Kawasaki-shi, Kanagawa, Japan

Site Status

Yokohama City University Hospital

Yokohama, Kanagawa, Japan

Site Status

Yokosuka Kyosai Hospital

Yokosuka, Kanagawa, Japan

Site Status

Social Welfare Organization Imperial Gift Foundation, Inc. Saiseikai Kumamoto Hospital

Kumamoto, Kumamoto, Japan

Site Status

Osaki Citizen Hospital

Ōsaki, Miyagi, Japan

Site Status

Miyazaki Prefectural Miyazaki Hospital

Miyazaki, Miyazaki, Japan

Site Status

Shinshu University Hospital

Matsumoto, Nagano, Japan

Site Status

NHO Kinki Chuo Chest Medical Center

Sakai, Osaka Japan, Japan

Site Status

Kawaguchi Municipal Medical Center

Kawaguchi-shi, Saitama, Japan

Site Status

Seirei Hamamatsu General Hospital

Hamamatsu, Shizuoka, Japan

Site Status

Hamamatsu Medical Center

Hamamatsu, Shizuoka, Japan, Japan

Site Status

Ome Medical Center

Ome-shi, Tokyo, Japan

Site Status

Hospital Sultanah Bahiyah

Alor Star, Kedah, Malaysia

Site Status

Raja Perempuan Zainab II Hospital

Kota Bharu, Kelantan, Malaysia

Site Status

Hospital Canselor Tuanku Muhriz UKM

Cheras, Kuala Lumpur, Malaysia

Site Status

Sarawak General Hospital

Kuching, Sarawak, Malaysia

Site Status

University of Malaya Medical Centre

Kuala Lumpur, , Malaysia

Site Status

Hospital III Goyeneche

Cercado, Arequipa, Peru

Site Status

Instituto Nacional De Enfermedades Neoplasicas

Surquillo, Lima, Peru, Peru

Site Status

Hospital IV - Alberto Sabogal Sologuren Red Asistencial Sabogal

Bellavista, Provincia Constitucional del Callao, Peru

Site Status

Centro Medico Monte Carmelo

Arequipa, , Peru

Site Status

Clinic Vallesur Arequipa

Arequipa, , Peru

Site Status

Hospital de Apoyo Maria Auxiliadora

Lima, , Peru

Site Status

Clnica San Antonio

Trujillo, , Peru

Site Status

Cebu Doctors University Hospital

Cebu City, Cebu, Philippines

Site Status

Chong Hua Hospital

Cebu City, Cebu, Philippines

Site Status

Perpetual Succour Hospital

Cebu City, Central Visayas, Philippines

Site Status

Davao Doctors Hospital

Davao City, Davao Del Sur, Philippines

Site Status

West Visayas State University Medical Center

Iloilo City, Iloilo, Philippines

Site Status

Asian Hospital And Medical Center

Muntinlupa, National Capital Region, Philippines

Site Status

Veterans Memorial Medical Center

Quezon City, National Capital Region, Philippines

Site Status

St. Lukes Medical Center

Quezon City, NCR, Philippines

Site Status

Riverside Medical Center Inc

Bacolod City, Negros Occidental, Philippines

Site Status

St. Paul's Hospital of Iloilo, Inc.

Iloilo City, Western Visayas, Philippines

Site Status

Philippine General Hospital

Manila, , Philippines

Site Status

Centrum Onkologii im. Prof. F. Lukaszczyka w Bydgoszczy

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie

Lublin, Lublin Voivodeship, Poland

Site Status

Warminsko Mazurskie Centrum Chorob Pluc w Olsztynie

Olsztyn, Warmian-Masurian Voivodeship, Poland

Site Status

Instytut MSF Sp. z o.o.

Lodz, , Poland

Site Status

NZOZ Neuromed M. i M. Nastaj Sp.P

Lublin, , Poland

Site Status

Med-Polonia Sp. z o.o.

Poznan, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku Sp. z o.o.

Słupsk, , Poland

Site Status

Clincial Centre of Serbia

Belgrade, , Serbia

Site Status

Institute for Pulmonary Diseases of Vojvodina

Kamenitz, , Serbia

Site Status

University Clinical Centre of Kragujevac

Kragujevac, , Serbia

Site Status

GVI Oncology, Langenhoven Drive Oncology Centre

Port Elizabeth, Eastern Cape, South Africa

Site Status

University of Pretoria and Steve Biko Academic Hospital Complex

Pretoria, Gauteng, South Africa

Site Status

Life Wilgers Hospital Wilgers Oncology Centre

Pretoria, Gauteng, South Africa

Site Status

Dr W M Szpak Inc - Rainbow Oncology

Athlone Park, KwaZulu-Natal, South Africa

Site Status

Abraham Oncology

Richards Bay, KwaZulu-Natal, South Africa

Site Status

The Catholic University Of Korea, St. Vincent's Hospital

Suwon, Gyeonggi-do, South Korea

Site Status

Ajou University Hospital

Suwon, Gyeonggi-do, South Korea

Site Status

Jeonbuk National University Hospital

Jeonju, Jeollabuk-do, South Korea

Site Status

Chungbuk National University Hospital

Cheongju-si, North Chungcheong, South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

Korea University Anam Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

The Catholic University of Korea, Seoul St. Mary's Hospital

Seoul, , South Korea

Site Status

Korea University Guro Hospital

Seoul, , South Korea

Site Status

Hospital General Universitario de Elche

Alicante, , Spain

Site Status

UOMI Cancer Center-Clinica Tres Torres

Barcelona, , Spain

Site Status

Hospital Quironsalud Barcelona

Barcelona, , Spain

Site Status

Complejo Hospitalario de Jaen (University Hospital Ciudad De Jaen)

Jaén, , Spain

Site Status

Hospital Universitario San Francisco de Asis

Madrid, , Spain

Site Status

Hospital Unifersitario Fundacion Jimenez Diaz

Madrid, , Spain

Site Status

Hospital Universitario Fundacion Jimenez Diaz

Madrid, , Spain

Site Status

Hospital Universitario Fundacion Alcorcon

Madrid, , Spain

Site Status

Hospital De Mataro

Mataró, , Spain

Site Status

Hospital Quironsalud Malaga

Málaga, , Spain

Site Status

Hospital Universitario Central de Asturias

Oviedo, , Spain

Site Status

Hospital Universitario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Universitario Nuestra Senora De Valme

Seville, , Spain

Site Status

Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulev

Valencia, , Spain

Site Status

Hospital Quironsalud Valencia

Valencia, , Spain

Site Status

Tri-Service General Hospital

Neihu, Taipei, Taiwan

Site Status

National Taiwan University Hospital (NTUH)

Taipei, Zhongzheng Dist, Taiwan

Site Status

Dalin Tzu chi General Hospital - Buddhist Tzu chi Medical Foundation

Chiayi City, , Taiwan

Site Status

National Taiwan University Hospital Yun-Lin Branch

Douliu, , Taiwan

Site Status

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, , Taiwan

Site Status

Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital

Kaohsiung County, , Taiwan

Site Status

Taipei Medical University (TMU) - Shuang Ho Hospital (SHH)

New Taipei City, , Taiwan

Site Status

Chung Shan Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

National Cheng Kung University Hospital

Tainan, , Taiwan

Site Status

Taipei Veterans General Hospital

Taipei, , Taiwan

Site Status

Mahidol University - Siriraj Hospital - Siriraj Clinical Research Center (SICRC)

Bangkoknoi, Bangkok, Thailand

Site Status

Chiangrai Prachanukroh Hospital

Muang, Changwat Chiang Rai, Thailand

Site Status

Naresuan University Hospital

Muang, Changwat Phitsanulok, Thailand

Site Status

Prince Of Songkla Hospital, Prince Of Songkhla University

Hat Yai, Changwat Songkhla, Thailand

Site Status

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University

Muang, Chiang Mai, Thailand

Site Status

Chulabhorn Hospital

Talat Bang Khen, Lak Si, Thailand

Site Status

Faculty of Medicine Vajira Hospital, Navamindradhiraj University

Bangkok, , Thailand

Site Status

King Chulalongkorn Memorial Hospital, Chulalongkom University

Bangkok, , Thailand

Site Status

Adana Ortadogu Hospital

Seyhan, Adana, Turkey (Türkiye)

Site Status

Gulhane Training and Research Hospital

Keçiören, Ankara, Turkey (Türkiye)

Site Status

Gazi University Faculty of Medicine

Yenimahalle, Ankara, Turkey (Türkiye)

Site Status

Trakya University Faculty of Medicine

İskender, Edirne, Turkey (Türkiye)

Site Status

Ondokuz Mayis University Health Practice and Research Hospital

Atakum, Samsun, Turkey (Türkiye)

Site Status

Medical Park Seyhan Hospital

Adana, , Turkey (Türkiye)

Site Status

Adana City Training and Research Hospital

Adana, , Turkey (Türkiye)

Site Status

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Ankara, , Turkey (Türkiye)

Site Status

Memorial Ankara Hospital

Ankara, , Turkey (Türkiye)

Site Status

Liv Hospital Ankara

Ankara, , Turkey (Türkiye)

Site Status

Ankara Bilkent City Hospital

Ankara, , Turkey (Türkiye)

Site Status

Uludag University Medical Faculty

Bursa, , Turkey (Türkiye)

Site Status

Medical Point Gaziantep Hospital

Gaziantep, , Turkey (Türkiye)

Site Status

Bezmialem Foundation University Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Yeditepe University Kosuyolu Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Medeniyet University Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Kocaeli Universitesi Tip Fakultesi

Kocaeli, , Turkey (Türkiye)

Site Status

Necmettin Erbakan University Meram Medical Faculty

Konya, , Turkey (Türkiye)

Site Status

Sakarya Universitesi Tip Fakultesi

Sakarya, , Turkey (Türkiye)

Site Status

Namik Kemal Universitesi Hastanesi

Tekirdağ, , Turkey (Türkiye)

Site Status

Nottingham University Hospitals NHS Trust - Nottingham City Hospital

Nottingham, Nottinghamshire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Austria Brazil Bulgaria Chile France Georgia Germany Italy Japan Malaysia Peru Philippines Poland Serbia South Africa South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-508336-57

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

2024-514304-14-00

Identifier Type: OTHER

Identifier Source: secondary_id

20210033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.